BODALCHEM Stock Overview
Bodal Chemicals Limited manufactures and sells dyestuffs, dyes intermediates, and other chemicals in India.
Bodal Chemicals Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||₹82.25|
|52 Week High||₹149.95|
|52 Week Low||₹76.00|
|1 Month Change||-11.75%|
|3 Month Change||-22.73%|
|1 Year Change||-18.48%|
|3 Year Change||-17.42%|
|5 Year Change||-48.01%|
|Change since IPO||198.55%|
Recent News & Updates
|BODALCHEM||IN Chemicals||IN Market|
Return vs Industry: BODALCHEM underperformed the Indian Chemicals industry which returned -1.5% over the past year.
Return vs Market: BODALCHEM underperformed the Indian Market which returned -0.9% over the past year.
|BODALCHEM Average Weekly Movement||6.2%|
|Chemicals Industry Average Movement||6.8%|
|Market Average Movement||6.9%|
|10% most volatile stocks in IN Market||9.9%|
|10% least volatile stocks in IN Market||4.5%|
Stable Share Price: BODALCHEM is not significantly more volatile than the rest of Indian stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: BODALCHEM's weekly volatility (6%) has been stable over the past year.
About the Company
Bodal Chemicals Limited manufactures and sells dyestuffs, dyes intermediates, and other chemicals in India. The company’s dye intermediates primarily include vinyl sulphone ester, ortho anisidine vinyl sulphone, meta ureido aniline, H. acid, Bronner's vinyl sulphone, vinyl sulphone paracresidine base, 6-nitro 1-diazo-2naphthol 4-sulphonic acid, sulpho para vinyl sulphone, sulpho tobias acid, vinyl sulphone ester of 2:5 di methoxy aniline, sulpho ortho anisidine vinyl sulphone, F.C. acid, 1:2:4 diazo, K–acid, benzedine di sulphonic acid, benzanilide vinyl sulphone, and gamma acid. It also provides reactive, acid, and direct dyes for textile, leather, and paper industries; and sulphuric acid, chloro sulphonic acid, liquid SO3, oleums, beta napthol, linear alkyl benzene sulphonic acid, and acetanilide that are used as raw materials for the production of dye intermediates.
Bodal Chemicals Fundamentals Summary
|BODALCHEM fundamental statistics|
Is BODALCHEM overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|BODALCHEM income statement (TTM)|
|Cost of Revenue||₹11.53b|
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
|Earnings per share (EPS)||8.79|
|Net Profit Margin||5.25%|
How did BODALCHEM perform over the long term?See historical performance and comparison
1.0%Current Dividend Yield
Is BODALCHEM undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 2/6
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for BODALCHEM?
Other financial metrics that can be useful for relative valuation.
|What is BODALCHEM's n/a Ratio?|
Price to Earnings Ratio vs Peers
How does BODALCHEM's PE Ratio compare to its peers?
|BODALCHEM PE Ratio vs Peers|
|Company||PE||Estimated Growth||Market Cap|
Price-To-Earnings vs Peers: BODALCHEM is good value based on its Price-To-Earnings Ratio (9.4x) compared to the peer average (14.5x).
Price to Earnings Ratio vs Industry
How does BODALCHEM's PE Ratio compare vs other companies in the Indian Chemicals Industry?
Price-To-Earnings vs Industry: BODALCHEM is good value based on its Price-To-Earnings Ratio (9.4x) compared to the Indian Chemicals industry average (16.9x)
Price to Earnings Ratio vs Fair Ratio
What is BODALCHEM's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PE Ratio||9.4x|
|Fair PE Ratio||n/a|
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate BODALCHEM's Price-To-Earnings Fair Ratio for valuation analysis.
Share Price vs Fair Value
What is the Fair Price of BODALCHEM when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: BODALCHEM (₹82.25) is trading above our estimate of fair value (₹11.91)
Significantly Below Fair Value: BODALCHEM is trading above our estimate of fair value.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate BODALCHEM's PEG Ratio to determine if it is good value.
Discover undervalued companies
How is Bodal Chemicals forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Future Growth Score0/6
Future Growth Score 0/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted Materials industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Bodal Chemicals has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Discover growth companies
How has Bodal Chemicals performed over the past 5 years?
Past Performance Score4/6
Past Performance Score 4/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: BODALCHEM has high quality earnings.
Growing Profit Margin: BODALCHEM's current net profit margins (5.3%) are higher than last year (3.4%).
Past Earnings Growth Analysis
Earnings Trend: BODALCHEM's earnings have declined by 16% per year over the past 5 years.
Accelerating Growth: BODALCHEM's earnings growth over the past year (156.5%) exceeds its 5-year average (-16% per year).
Earnings vs Industry: BODALCHEM earnings growth over the past year (156.5%) exceeded the Chemicals industry 29.6%.
Return on Equity
High ROE: BODALCHEM's Return on Equity (9.4%) is considered low.
Discover strong past performing companies
How is Bodal Chemicals's financial position?
Financial Health Score3/6
Financial Health Score 3/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: BODALCHEM's short term assets (₹11.3B) exceed its short term liabilities (₹8.0B).
Long Term Liabilities: BODALCHEM's short term assets (₹11.3B) exceed its long term liabilities (₹2.7B).
Debt to Equity History and Analysis
Debt Level: BODALCHEM's net debt to equity ratio (62.8%) is considered high.
Reducing Debt: BODALCHEM's debt to equity ratio has increased from 41.3% to 64.2% over the past 5 years.
Debt Coverage: BODALCHEM's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: BODALCHEM's interest payments on its debt are well covered by EBIT (5.9x coverage).
Discover healthy companies
What is Bodal Chemicals's current dividend yield, its reliability and sustainability?
Dividend Score 3/6
Future Dividend Coverage
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: BODALCHEM's dividend (0.97%) is higher than the bottom 25% of dividend payers in the Indian market (0.43%).
High Dividend: BODALCHEM's dividend (0.97%) is low compared to the top 25% of dividend payers in the Indian market (1.89%).
Stability and Growth of Payments
Stable Dividend: BODALCHEM's dividend payments have been volatile in the past 10 years.
Growing Dividend: BODALCHEM's dividend payments have increased over the past 10 years.
Earnings Payout to Shareholders
Earnings Coverage: With its low payout ratio (9.1%), BODALCHEM's dividend payments are thoroughly covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: BODALCHEM is paying a dividend but the company has no free cash flows.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Sureshbhai Patel (65 yo)
Mr. Sureshbhai Jayantibhai Patel is Founder of Bodal Chemicals Pvt. Ltd. Mr. Patel has been Chairman and Managing Director of Bodal Chemicals Ltd.(formerly Bodal Chemicals Limited) since May 13, 2006 and...
CEO Compensation Analysis
Compensation vs Market: Sureshbhai's total compensation ($USD475.78K) is above average for companies of similar size in the Indian market ($USD38.38K).
Compensation vs Earnings: Sureshbhai's compensation has been consistent with company performance over the past year.
Experienced Management: BODALCHEM's management team is seasoned and experienced (9.5 years average tenure).
Experienced Board: BODALCHEM's board of directors are considered experienced (9.7 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Bodal Chemicals Limited's employee growth, exchange listings and data sources
- Name: Bodal Chemicals Limited
- Ticker: BODALCHEM
- Exchange: NSEI
- Founded: 1986
- Industry: Commodity Chemicals
- Sector: Materials
- Implied Market Cap: ₹10.068b
- Shares outstanding: 122.48m
- Website: https://www.bodal.com
Number of Employees
- Bodal Chemicals Limited
- Plot No. 123-124
- Phase - I
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/06/25 00:00|
|End of Day Share Price||2022/06/24 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.